0000000000725620

AUTHOR

P. Guerrieri

showing 2 related works from this author

Temozolomide (TMZ) in radio-chemotherapy combined schedule for treatment of newly-diagnosed high-grade gliomas (HGG)

2005

1578 Background: Temozolomide (TMZ) is an oral alkylating agent known to cross the blood-brain barrier with efficacy against HGG and a favourable safety profile compared to conventional chemotherap...

OncologyCancer Researchmedicine.medical_specialtyScheduleTemozolomideSettore MED/06 - Oncologia Medicabusiness.industryNewly diagnosedSurgerySafety profileOncologyInternal medicinemedicinebusinessmedicine.drugRadio chemotherapyJournal of Clinical Oncology
researchProduct

Splenic Irradiation (SI) in Myelofibrosis: Outcomes and Toxicity of Three Radiation Schedule

2008

OncologyCancer Researchmedicine.medical_specialtyScheduleRadiationbusiness.industrymedicine.diseaseSurgeryOncologyInternal medicineToxicitymedicineRadiology Nuclear Medicine and imagingSplenic irradiationbusinessMyelofibrosisInternational Journal of Radiation Oncology*Biology*Physics
researchProduct